1-20 of 278 results for subject:"Medical equipment"
Librarians' tools
- Search time
- 0.257 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:"Medical equipment"
- We searched for
- subject_t:"Medical equipment" OR subject_t:"Medical devices" OR subject_ses:91970
Type
House
Session
Month
Department
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask Her Majesty's Government what preventive measures they have put in place to protect the NHS from running short of essential medicines and medical supplies in preparation for a possible no-deal Brexit on 31 October or any other date; and what estimate they have made of the costs incurred from such measures.
To ask Her Majesty's Government what preventive measures they have put in place to protect the NHS from running short of essential medicines and medical supplies in preparation for a possible no-deal Brexit on 31 October or any other date; and what estimate they have made of the costs incurred from such measures.
It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.
To ask the Secretary of State for Health and Social Care, what plans his Department has to widen the NHS England criteria under which diabetes patients can receive the Freestyle Libre glucose monitoring device on prescription to include type 2 diabetics.
To ask the Secretary of State for Health and Social Care, what plans his Department has to widen the NHS England criteria under which diabetes patients can receive the Freestyle Libre glucose monitoring device on prescription to include type 2 diabetics.
Clinical commissioning groups are responsible for commissioning diabetes services for their local populations. They are also expected to take National Institute for Health and Care Excellence (NICE) guidelines into consideration when making their decisions. NICE currently recommends not routinely offering self-monitoring of blood glucose levels for adults with type 2 diabetes unless the person:
- is on insulin;
- or there is evidence of hypoglycaemic episodes;
- or the person is on medication that may increase their risk of hypoglycaemia while driving or operating machinery;
- or the person is pregnant or is planning to become pregnant.
The evidence base for the benefits and cost-effectiveness of flash glucose monitoring for people with type 2 diabetes is still developing, and NICE will continue to monitor the evidence and relevant research.
To ask the Secretary of State for Health and Social Care, what the annual cost to the NHS is of (a) pharmaceutical drugs, (b) examination gloves, (c) disposable aprons, (d) other medical consumables, (e) medical scanning devices and (f) other equipment.
To ask the Secretary of State for Health and Social Care, what the annual cost to the NHS is of (a) pharmaceutical drugs, (b) examination gloves, (c) disposable aprons, (d) other medical consumables, (e) medical scanning devices and (f) other equipment.
Expenditure on medicines in 2018/19 financial year in England in primary care and secondary care was £15.4 billion.
All National Health Service trusts as autonomous entities record their data locally. NHS Improvement and NHS Digital have been working to centralise purchase order and invoice data centrally to provide better national data visibility on common goods and supplies (everyday hospital consumables; high value healthcare consumables; common goods and capital equipment). Spend is reported by NHS trusts on the NHS Spend Comparison Service for England; common goods and supplies contains £5.6 billion of expenditure. Reviewing the categories requested below within the spend comparison service shows:
Expenditure on examination gloves for 2018/19 financial year was £41.7 million; expenditure on disposable aprons was £4.9 million and expenditure on medical scanning devices was £359.5 million. There are no categories on the Spend Comparison Service for ‘other medical consumables’ and ‘other equipment’.
The figures above will exclude any spend not reported through the Spend Comparison Service.
NHS Trusts are autonomous entities who will make their own procurement decisions based on local pressures and demands. Collaborative procurement is promoted across healthcare to make the most of the NHS budget ensuring value for money is delivered. NHS trusts work with other local hospitals, regional procurement hubs and the national framework organisations that the Department has established - Commercial Medicines Unit and NHS Supply Chain Coordination Ltd for medicines and common goods and supplies respectively – to purchase these supplies.
NHS trusts will make individual decisions on what to do with products which expire, are decommissioned or are at the end of their lifecycle. The decision will depend on the value of the asset and whether the asset has any ongoing use. There are charities which will collect expired products for use in third world countries and there are also specialist auctioneers who will sell equipment with residual life and use. Quite often old imaging equipment will be purchased by vets.
To ask the Secretary of State for Health and Social Care, how NHS Trusts procure (a) pharmaceutical drugs, (b) medical consumables, (c) medical devices and (d) medical equipment; and what happens to those items when they (i) expire, (ii) are decommissioned and (iii) reach the end of their life cycle.
To ask the Secretary of State for Health and Social Care, how NHS Trusts procure (a) pharmaceutical drugs, (b) medical consumables, (c) medical devices and (d) medical equipment; and what happens to those items when they (i) expire, (ii) are decommissioned and (iii) reach the end of their life cycle.
Expenditure on medicines in 2018/19 financial year in England in primary care and secondary care was £15.4 billion.
All National Health Service trusts as autonomous entities record their data locally. NHS Improvement and NHS Digital have been working to centralise purchase order and invoice data centrally to provide better national data visibility on common goods and supplies (everyday hospital consumables; high value healthcare consumables; common goods and capital equipment). Spend is reported by NHS trusts on the NHS Spend Comparison Service for England; common goods and supplies contains £5.6 billion of expenditure. Reviewing the categories requested below within the spend comparison service shows:
Expenditure on examination gloves for 2018/19 financial year was £41.7 million; expenditure on disposable aprons was £4.9 million and expenditure on medical scanning devices was £359.5 million. There are no categories on the Spend Comparison Service for ‘other medical consumables’ and ‘other equipment’.
The figures above will exclude any spend not reported through the Spend Comparison Service.
NHS Trusts are autonomous entities who will make their own procurement decisions based on local pressures and demands. Collaborative procurement is promoted across healthcare to make the most of the NHS budget ensuring value for money is delivered. NHS trusts work with other local hospitals, regional procurement hubs and the national framework organisations that the Department has established - Commercial Medicines Unit and NHS Supply Chain Coordination Ltd for medicines and common goods and supplies respectively – to purchase these supplies.
NHS trusts will make individual decisions on what to do with products which expire, are decommissioned or are at the end of their lifecycle. The decision will depend on the value of the asset and whether the asset has any ongoing use. There are charities which will collect expired products for use in third world countries and there are also specialist auctioneers who will sell equipment with residual life and use. Quite often old imaging equipment will be purchased by vets.
To ask Her Majesty's Government whether they intend to cease the prescription of dry powder inhalers in England apart from in exceptional circumstances; and if so, when.
To ask Her Majesty's Government whether they intend to cease the prescription of dry powder inhalers in England apart from in exceptional circumstances; and if so, when.
It is the intention of the National Health Service, as set out in its Long Term Plan commitment, to reduce the use of traditional inhalers with higher levels of fluorinated gases. There are devices available which use significantly less fluorinated gases and dry powder devices, which do not use fluorinated gases, unlike traditional metered dose devices.
This year, the National Institute of Health and Care Excellence has published a Patient Decision Aid to help people with asthma, alongside health professionals, to identify which inhalers could meet their needs and control their symptoms. Where several inhalers could be viable options, the decision aid helps clinicians and patients choose the more environmentally friendly option, with a lower carbon footprint. The British Thoracic Society have included device carbon impacts in their recently published asthma guidelines.
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the risks posed to people living with disabilities by a lack of availability of (a) medicines and (b) essential medical equipment in the event of the UK leaving the EU without a...
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the risks posed to people living with disabilities by a lack of availability of (a) medicines and (b) essential medical equipment in the event of the UK leaving the EU without a...
The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.
The Department, as part of our EU exit preparations, has analysed the supply chains of over 12,000 licensed medicines used by patients in the United Kingdom and close to half a million product lines of medical devices and clinical consumables with an EU/European Economic Area touchpoint. This approach means that the medicines and medical equipment used by people living with disabilities are included within our planning.
We continue to implement a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:
To ask the Secretary of State for Health and Social Care, if he will make it his policy for NHS England to require (a) Clinical Commissioning Groups and (b) NHS trusts that have formularies which do not list all of the medical devices available on Part IX of the Drug...
To ask the Secretary of State for Health and Social Care, if he will make it his policy for NHS England to require (a) Clinical Commissioning Groups and (b) NHS trusts that have formularies which do not list all of the medical devices available on Part IX of the Drug...
The Government has no plans to change current policies. Decisions about the provision of medical devices available on Part IX of the Drug Tariff are a matter for local clinical commissioning groups and National Health Service trusts, taking account of the needs of their local populations.
Lords debate on Queen's speech (sixth day) on health, social care, education, culture, welfare and pensions. Motion on royal address agreed to nemine dissentiente.
Lords debate on Queen's speech (sixth day) on health, social care, education, culture, welfare and pensions. Motion on royal address agreed to nemine dissentiente.
My Lords, the Queen’s Speech will deliver EU exit alongside an ambitious programme of domestic reform that delivers real change to the people of this country. It is my pleasure to update noble Lords on the Government’s plans for the next Session for the Department of Health and Social Care,...
My Lords, the Queen’s Speech will deliver EU exit alongside an ambitious programme of domestic reform that delivers real change to the people of this country. It is my pleasure to update noble Lords on the Government’s plans for the next Session for the Department of Health and Social Care,...
My Lords, I thank the Minister for that introduction. She need not worry about repeating herself; I do that all too often—and I write my own speeches, so she has my sympathy. I am really looking forward to hearing speeches from around the House, but it is a disappointment that...
My Lords, I thank the Minister for that introduction. She need not worry about repeating herself; I do that all too often—and I write my own speeches, so she has my sympathy. I am really looking forward to hearing speeches from around the House, but it is a disappointment that...
My Lords, I want to confine my remarks to the area of education, of which the Queen’s Speech says basically, “Motherhood and apple pie”. Could anyone have cause to disagree with the statement that all young people will,
“have access to an excellent education, unlocking their full potential and preparing them...
My Lords, I want to confine my remarks to the area of education, of which the Queen’s Speech says basically, “Motherhood and apple pie”. Could anyone have cause to disagree with the statement that all young people will,
“have access to an excellent education, unlocking their full potential and preparing them...
My Lords, I propose to speak about social care for disabled and older people, which of course impacts on their health and well-being. This area has been deeply neglected in recent years. We are, sadly, looking at a series of failures in this sector: failure to invest in older and...
My Lords, I propose to speak about social care for disabled and older people, which of course impacts on their health and well-being. This area has been deeply neglected in recent years. We are, sadly, looking at a series of failures in this sector: failure to invest in older and...
My Lords, it is always a privilege to follow the noble Baroness, Lady Campbell, in these debates. I shall to try to draw on her remarks as I make mine. I draw the House’s attention to my entry in the register of Members’ interests.
I welcome the proposals in the Queen’s...
My Lords, it is always a privilege to follow the noble Baroness, Lady Campbell, in these debates. I shall to try to draw on her remarks as I make mine. I draw the House’s attention to my entry in the register of Members’ interests.
I welcome the proposals in the Queen’s...
My Lords, I regret the cursory reference in the gracious Speech to the social care needs of the old in this country. The Minister’s statement this afternoon has been confined to sums of money, some of which have already been announced. It was money that she spoke of; there was...
My Lords, I regret the cursory reference in the gracious Speech to the social care needs of the old in this country. The Minister’s statement this afternoon has been confined to sums of money, some of which have already been announced. It was money that she spoke of; there was...
It is a great pleasure to follow the noble Baroness, Lady Bakewell. As a former council leader, I am very familiar with some of the issues she raised here today, but I shall confine my remarks to the worsening conditions of the least well off in our country. They deserve...
It is a great pleasure to follow the noble Baroness, Lady Bakewell. As a former council leader, I am very familiar with some of the issues she raised here today, but I shall confine my remarks to the worsening conditions of the least well off in our country. They deserve...
My Lords, many noble Lords will know that I have a background in health, and I continue to be a great supporter of the National Health Service, so they will not be surprised when I address my comments to health and social care. In doing so, I recognise the contribution...
My Lords, many noble Lords will know that I have a background in health, and I continue to be a great supporter of the National Health Service, so they will not be surprised when I address my comments to health and social care. In doing so, I recognise the contribution...
My Lords, first, I say to the right reverend Prelate how much we appreciated her speech today and on other occasions. It takes me back 25 years, to when I was Leader of the House and invited the then Archbishop of Canterbury to have dinner with me, because I thought...
My Lords, first, I say to the right reverend Prelate how much we appreciated her speech today and on other occasions. It takes me back 25 years, to when I was Leader of the House and invited the then Archbishop of Canterbury to have dinner with me, because I thought...
My Lords, children and health have been mentioned in some very eloquent speeches already. I want to talk about young people’s health, particularly early inequalities in health due to many of the factors expressed so eloquently by my noble friend Lady Sherlock.
The gracious Speech did not refer to the needs...
My Lords, children and health have been mentioned in some very eloquent speeches already. I want to talk about young people’s health, particularly early inequalities in health due to many of the factors expressed so eloquently by my noble friend Lady Sherlock.
The gracious Speech did not refer to the needs...
My Lords, I want to focus the attention of the House on an industry that brings £127 billion a year to the UK economy, attracts £24 billion of spending in the UK from abroad, contributes a further £7 billion a year in tax and provides 3 million jobs in the...
My Lords, I want to focus the attention of the House on an industry that brings £127 billion a year to the UK economy, attracts £24 billion of spending in the UK from abroad, contributes a further £7 billion a year in tax and provides 3 million jobs in the...